canoo_logoBLK.png
Canoo’s Oklahoma City Manufacturing Facility Achieves Final Activation as First Automotive Foreign-Trade Zone in the State of Oklahoma
September 19, 2024 07:00 ET | Canoo, Inc.
Canoo’s Oklahoma City Manufacturing Facility Achieves Final Activation as First Automotive Foreign-Trade Zone in the State of Oklahoma
Sable_Logo_New.jpg
Sable Receives Multiple Anomalous Cu-Au-Ag Results from the Perk Rocky Project in British Columbia
September 19, 2024 07:00 ET | Sable Resources Ltd.
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ("Sable" or the "Company") (TSXV:SAE | OTCQB:SBLRF) is pleased to announce that it has received preliminary...
ACELYRIN, INC. Logo.jpg
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET | ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
BTAI-logo-png-220x123.png
BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation
September 19, 2024 07:00 ET | BioXcel Therapeutics
Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia Submitted protocol to FDA for TRANQUILITY In-Care pivotal Phase 3 trial...
OTC Markets-News Trading logo.png
OTC Markets Group Welcomes Slam Corp. to OTCQX
September 19, 2024 07:00 ET | OTC Markets
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Slam Corp....
APF_logo_Black.png
Multilingual Fentanyl Awareness Resources Released
September 19, 2024 07:00 ET | Addiction Policy Forum
Addiction Policy Forum has launched fentanyl education resources in 12 languages to help more communities understand the dangers of counterfeit pills.
ValOre Partners with VRIFY to Leverage AI Mineral Targeting Platform to Accelerate Discovery Process
September 19, 2024 07:00 ET | ValOre Metals Corporation
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today announced a partnership with VRIFY which...
Tonix2.jpg
Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
September 19, 2024 07:00 ET | Tonix Pharmaceuticals Holding Corp.
New patent expected to expire in 2030 Tosymra® (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE)...
CW Only RGB.jpg.jpeg
CW Petroleum Corp (OTCQB: CWPE) Yahoo Finance Stock Quote Data from OTC Markets Not Functioning Properly for CWPE
September 19, 2024 07:00 ET | CW Petroleum Corp
Katy, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its...
gainlogo.png
Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
September 19, 2024 07:00 ET | Gain Therapeutics, Inc.
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...